Sort
82,697 grants matching “vaccine development”
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH
$1,994,885John Jay Treanor · University Of Rochester · N01 · FY2019 · AI
Branch Clinical Research Core
$1,994,665Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2010 · CA
Role of the microbiota in immunity
$1,994,610Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Development of a VesiVax HIV Vaccine Formulation
$1,994,571Sam On Ho · Molecular Express, Inc. · N44 · FY2022 · AI
The development of probiotic yeast as an inexpensive vaccine delivery platform
$1,994,217Tracey Jane Lamb · Emory University · DP2 · FY2013 · AI
Novel Therapeutic Strategies in Human Myeloid Leukemias
$1,994,148Dana-Farber Cancer Institute · P01 · FY2002 · CA
Specialized Program of Research Excellence
$1,993,608Jennifer R Grandis · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · CA
Acquisition of cryo-electron microscope
$1,993,586Terje Dokland · University Of Alabama At Birmingham · S10 · FY2020 · OD
GHESKIO Clinical Trials Unit
$1,993,512Jean William Pape · Gheskio Center · UM1 · FY2023 · AI
SPORE in Prostate Cancer
$1,993,426Samuel R Denmeade · Johns Hopkins University · P50 · FY2017 · CA
Core--Vector
$1,993,136Beth Israel Deaconess Medical Center · U19 · FY2005 · AI
Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA)
$1,992,875Arnab Kumar Chatterjee · Scripps Research Institute, The · N01 · FY2025 · AI
Enhancing T Cell Therapy of Cancer
$1,992,319Helen E Heslop · Baylor College Of Medicine · P01 · FY2010 · CA
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$1,992,211David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
$1,991,797T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
SPORE in Lung Cancer
$1,991,619Eric B. Haura · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2012 · CA
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$1,991,523Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Immunobiology and Pathogenesis of Pulmonary Tularemia (Metzger, PD)
$1,990,991Dennis W. Metzger · Albany Medical College · P01 · FY2015 · AI
Center for Immunotherapeutic Transport Oncophysics
$1,990,957Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2016 · CA
Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA)
$1,990,835Arnab Kumar Chatterjee · Scripps Research Institute, The · N01 · FY2024 · AI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,990,761Thomas A Waldmann · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Vanderbilt HIV Clinical Trials Unit
$1,989,708Richard T D'aquila · Vanderbilt University · U01 · FY2008 · AI
Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection
$1,988,765Ananda W Goldrath · University Of California, San Diego · P01 · FY2018 · AI
Noroviruses and Epidemic Gastroenteritis
$1,988,093Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$1,987,442Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA